From Evidence to Practice in Low-Risk Thyroid Cancer - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Applying Evidence-Based Care to Low-Risk Thyroid Cancer

  • By

  • Lia D. Delaney

  • Carolyn D. Seib

  • October 30, 2026

Share

  • 1

    Guidelines increasingly endorse thyroid lobectomy for selected patients with low-risk differentiated thyroid cancer, with tumors smaller than 4 cm and no nodal metastases or other high-risk features.

  • 2

    Total thyroidectomy remains the treatment for approximately 60% to 80% of patients with low-risk thyroid cancer despite evidence supporting lobectomy.

  • 3

    In interviews and observations across 7 practices, surgeons most often favored performance feedback, but no single intervention was identified as optimal.

  • 4

    Surgeons often viewed practice-changing interventions as more applicable to colleagues than to themselves, while professional identity and individualized decision-making shaped views of change.

  • 5

    Future research should test stakeholder-informed interventions across diverse settings and support individualized care, including less-intensive treatment for appropriate patients.

Original Source(s)

Related Content